Anton Forsberg Morén
- Department of Clinical Neuroscience
- Centre for Psychiatry Research at CNS
- Molecular brain imaging of neurodegenerative disorders – Andrea Varrone's research group
About me
Core Facility Manager of the Brain Molecular Imaging Centre (BMIC) Researcher in the research group of Andrea Varrone working in the imaging field
with the technique Positron Emission Tomography (PET).
Research
My main research is using neuroimaging within neurodegenerative diseases mainly including Alzeimer’s Disease (AD) as well as other neurodegenerative disorders such as Parkinson’s Disease (PD) and Huntington’s Disease (HD). The main method used is Positron Emission Tomography (PET) using various biomarkers for Amyloid, Tau, and radioligands for neuroinflammation, etc.
My first years in PET research included the world first studies of in vivo amyloid PET imaging in mild cognitive impairment (MC) and longitudinal
changes of amyloid load in AD. I have after that continued AD research at the Karolinska PET center in Solna including several projects focusing on
evaluation and application of novel PET radioligands targeting amyloid and neuroinflammatory targets such as the Translocator protein (TSPO) in
microglia. Besides my focus on AD I have been and currently am involved in many other projects including studies of pathological changes in PD
investigating the serotonergic and dopaminergic systems and neuroinflammation, as well as developing novel radioligands targeting mutant
huntingtin in HD.During my 19 year long career within PET research I have become an expert in data analysis and modelling of PET data in humans as well as non-human primates. As part of my work here at Karolinska Institutet PET center I have also worked extensively with project management of academic projects as well as collaborations with industrial partners. Therefore my involvement and tasks within this application is clearly connected to both my interests in the research fields as well as my expertise in PET data analysis and project management.
Teaching
Organizer of the one week long research education course “Positron Emission Tomography Imaging of the CNS. Methodology and clinical applications".
Co-organizer of the Master course “Introduction to Brain Imaging in Neuroscience: With a Focus on MRI, PET, EEG and MEG Methods”.
Articles
- Article: BRAIN BEHAVIOR AND IMMUNITY. 2026;138:106954Kalpouzos G; Falahati F; Malmros J; Stenkrona P; Mouyobo CE; Mangialasche F; Varrone A; Moren AF; Papenberg G
- Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2026;29(8):pyag034Garcia-Olivares J; Yegla B; Ridler K; Rizzo G; Fan Z; Amenta AL; Moren AF; Halldin C; Stepanov V; Koch J; Yu C; Rubin J; Maletic V; Rabiner EA
- Article: ACS CHEMICAL NEUROSCIENCE. 2026;17(14):2660-2668Nag S; Sousa VC; Zou R; Moren AF; Datta P; Khani Y; Valade A; Vermeiren C; Motte P; Mercier J; Agren H; Halldin C; Varrone A
- Article: JOURNAL OF NUCLEAR MEDICINE. 2026;67(2):269-275Mortensen ACL; Mohajershojai T; Gustafsson A; Berglund H; Selvaraju RK; Hofstro C; Persson H; Ohlin M; Tran TA; More AF; Ochniewicz P; Zedenius J; Bernhardt P; Frejd FY; Nestor M
- Article: JOURNAL OF NEUROINFLAMMATION. 2025;22(1):270Balter LJ; Malmros J; Stenkrona P; Varrone A; Forsberg A; Gustavsson E; Mouyobo CE; Kalpouzos G; Papenberg G
- Article: JOURNAL OF NUCLEAR MEDICINE. 2025;66(10):1646-1651Rikken RM; Van De Giessen E; Brumberg J; Aarnio R; Joling M; More AF; Kerstens V; Moein MM; Nag S; Halldin C; Fazio P; Roos DS; Berendse HW; Kassiou M; Wahlroos S; Haaparanta-Solin M; Oikonen V; Schuit RC; Boellaard R; Windhorst AD; Jacobs AH; Lammertsma AA; Rinne JO; Varrone A; Golla SSV
- Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2025;12(8):100302Nery FC; Kaliszczak M; Suttle B; Jones L; Wu S; Xie J; Curiale G; Yesilalan E; Hirschhorn B; Wilkes D; Singh D; Bolin M; Nag S; Varrone A; Stenkrona P; Halldin C; Yachnin J; Arnold HM; Bullain S; Landen J; Gallagher D; Hering H
- Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(8):1606-1616Bolin M; Nag S; Arakawa R; Varrone A; Farde L; Martarello L; Kaliszczak MA; Halldin C; Moren AF
- Article: PCN REPORTS. 2025;4(2):e70123Sturchio A; Svensson JE; Tiger M; Moren AF; Varrone A; Svenningsson P; Okubo Y; Tateno A
- Article: SCIENCE TRANSLATIONAL MEDICINE. 2025;17(797):eadl1732Cook BE; Pickel TC; Nag S; Bolduc PN; Beshr R; Moren AF; Muste C; Boscutti G; Jiang D; Yuan L; Datta P; Ochniewicz P; Meynaq YK; Tang S-P; Plisson C; Amatruda M; Zhang Q; DuBois JM; Delavari A; Klein SK; Polyak I; Shoroye A; Girmay S; Halldin C; Martarello L; Peterson EA; Kaliszczak M
- Article: MOVEMENT DISORDERS. 2025;40(4):739-744Wallin J; Forsberg A; Svenningsson P
- Article: MOLECULES. 2025;30(6):1356Jia Z; Bolin M; Moren AF; Datta P; Asem H; Agren H; Langstrom B; Nordberg A; Halldin C; Nag S
- Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(2):352-364Ridler K; Rizzo G; Burstein ES; Forsberg Moren A; Stepanov V; Halldin C; Rabiner EA
- Article: ACS CHEMICAL NEUROSCIENCE. 2024;15(22):4210-4219Guarino DS; Azpiazu PM; Sunnemark D; Elmore CS; Bergare J; Artelsmair M; Nordvall G; Moren AF; Jia Z; Cortes-Gonzalez M; Mach R; Wilcox KC; Finnema S; Schou M; Varrone A
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024;25(14):7870Nag S; Datta P; Moren AF; Khani Y; Martarello L; Kaliszczak M; Halldin C
- Article: JOURNAL OF ALZHEIMERS DISEASE. 2024;98(4):1391-1401Mattsson P; Cselenyi Z; Moren AF; Freund-Levi Y; Wahlund L-O; Halldin C; Farde L
- Article: EJNMMI PHYSICS. 2023;10(1):72Matheson GJ; Ge L; Zhang M; Sun B; Tu Y; Zanderigo F; Moren AF; Ogden RT
- Article: JOURNAL OF NUCLEAR MEDICINE. 2023;64(10):1588-1593Cook BE; Nag S; Arakawa R; Lin EY-S; Stratman N; Guckian K; Hering H; Lulla M; Choi J; Salinas C; Genung NE; Moren AF; Bolin M; Boscutti G; Plisson C; Martarello L; Halldin C; Kaliszczak MA
- Article: ACS CHEMICAL NEUROSCIENCE. 2023;14(14):2560-2568Nag S; Bolin M; Datta P; Arakawa R; Moren AF; Maynaq YK; Lin E; Genung N; Hering H; Guckian K; Martarello L; Kaliszczak M; Halldin C
- Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2023;43(2):258-268Brumberg J; Aarnio R; Forsberg A; Marjamaki P; Kerstens V; Moein MM; Nag S; Wahlroos S; Kassiou M; Windhorst AD; Halldin C; Haaparanta-Solin M; Fazio P; Oikonen V; Rinne JO; Varrone A
- Show more
All other publications
- Preprint: BIORXIV. 2026Nag S; Sousa V; Forsberg Morén A; Tóth M; Khani Meynaq Y; Pedergnana E; Zou R; Valade A; Vermeiren C; Motte P; Mercier J; Zhang X; Svenningsson P; Ågren H; Halldin C; Varrone A
- Corrigendum: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2026;13(1):100425Nery FC; Kaliszczak M; Suttle B; Jones L; Wu S; Xie J; Curiale G; Yesilalan E; Hirschhorn B; Wilkes D; Singh D; Bolin M; Nag S; Varrone A; Stenkrona P; Moren AF; Halldin C; Yachnin J; Arnold HM; Bullain S; Landen J; Gallagher D; Hering H
- Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024;51:S818-S819Nag S; Moren AF; Sousa V; Datta P; Meynaq YK; Valade A; Vermeiren C; Motte P; Mercier J; Agren H; Halldin C; Varrone A
- Study protocol: BMC NEUROLOGY. 2024;24(1):111Svensson JE; Bolin M; Thor D; Williams PA; Brautaset R; Carlsson M; Sorensson P; Marlevi D; Spin-Neto R; Probst M; Hagman G; Moren AF; Kivipelto M; Plaven-Sigray P
- Preprint: MEDRXIV. 2024Svensson J; Bolin M; Thor D; Williams P; Brautaset R; Carlsson M; Sörensson P; Marlevi D; Spin-Neto R; Probst M; Hagman G; Morén AF; Kivipelto M; Plavén-Sigray P
- Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S26Nag S; Arakawa R; Datta P; Moren A; Varrone A; Moein MM; Bolin M; Lin E; Genung N; Martarello L; Kaliszczak M; Halldin C
- Corrigendum: MOVEMENT DISORDERS. 2020;35(12):2363-2364Fazio P; Fitzer-Attas CJ; Mrzljak L; Bronzova J; Nag S; Warner JH; Landwehrmeyer B; Al-Tawil N; Halldin C; Forsberg A; Ware J; Dilda V; Wood A; Sampaio C; Varrone A
- Editorial: BRAIN. 2020;143(9):2634-2636Moren AF; Varrone A
- Meeting abstract: NEUROIMAGE. 2010;52:S142Cselenyi Z; Jonhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnstroem P; Varnas K; Svensson S; Farde L
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S125-S126Nordberg A; Forsberg A; Kadir A; Almkvist O; Engler H; Langstrom B
- Doctoral thesis: 2008Amyloid imaging in Alzheimer’s disease and mild cognitive impairment by positron emission tomographyForsberg A
- Corrigendum: MOLECULAR IMAGING AND BIOLOGY. 2006;8(4):252Engler H; Forsberg A; Blomquist G; Larsson E; Savitcheva I; Wal A; Nordberg A; Langstrom B
- Conference publication: NEUROBIOLOGY OF AGING. 2006;27:S15Nordberg A; Forsberg A; Hengler H; Wall A; Blomquist G; Langström B
- Conference publication: NEUROBIOLOGY OF AGING. 2006;27:S6-S7Engler H; Forsberg A; Blomquist G; Larsson E; Savitcheva I; Wall A; Langström B; Nordberg A
- Conference publication: JOURNAL OF PSYCHOPHARMACOLOGY. 2004;18(3):A6Nordberg A; Almkvist O; Ausén B; Forsberg A; Kadir A; Engier H; Blomqvist G; Wall A; Långström B
Grants
- Alzheimer's Association1 January 2018Background The protein fragment beta-amyloid has long been studied as a key suspect molecule in Alzheimer’s. This fragment tends to accumulate into clumps called plaques, which may hinder nerve cell communication in the brain and lead to brain cell death. Beta-amyloid is produced from its parent molecule, amyloid precursor protein (APP), in a two-stage process. The enzyme Beta-secretase 1 (BACE1) begins the production process for beta-amyloid. Many research teams have studied whether blocking the activity of BACE1 could slow or prevent Alzheimer’sthese studies have either experienced side effects or are still ongoing. Recent studies suggest that beta-amyloid is present and maybe playing a role in early stage of Alzheimer’s, even before the loss of brain function is pronounced. Future studies, therefore, will need to focus on determining how beta-amyloid production changes during early stages of Alzheimer’s.<br /> Research Plan Using a new imaging brain scan tool, Dr. Anton Forsberg Morén and colleagues plan to determine BACE1 activity in the brains of two types of participants- 1) those who are cognitively unimpaired and 2) in those with mild cognitive impairment (MCI). This information will help assess how BACE1 activity differs in MCI. The researcher’s brain scan technique will feature a special compound (named [18F]PF-06684511), which can attach itself to BACE1 and emit a signal that can help “highlight” BACE1’s activity in the brain scans. The researchers will then assess how BACE1 activity differs in MCI brains compared with the cognitively unimpaired brains.<br /> Impact The study results could shed new light on how beta-amyloid production changes in the early stages of Alzheimer’s. It could also lead to future studies using the special molecule in brain scans. Ultimately, such work could help produce effective therapies for Alzheimer’s. <br />
Employments
- Researcher, Department of Clinical Neuroscience, Karolinska Institutet, 2018-
Degrees and Education
- Degree Of Doctor Of Philosophy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 2008